Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Skyrizi
Pharma
AbbVie shrugs off new J&J competition for fast-growing Skyrizi
Immunology med Skyrizi charted sales growth of 30.9% over 2026's quarter, bringing home $4.48 billion as AbbVie's top earner.
Zoey Becker
Apr 29, 2026 2:53pm
J&J's Tremfya retakes TV drug ad spending crown from AbbVie
Apr 8, 2026 11:44am
With win over AbbVie's Skyrizi, UCB's Bimzelx remains undefeated
Mar 11, 2026 11:29am
Super Bowl, Olympics defined TV drug ad spending in February
Mar 6, 2026 12:39pm
J&J's Tremfya roars into 2026 with massive January TV ad spend
Feb 11, 2026 12:33pm
AbbVie touts Skyrizi, Rinvoq prowess amid J&J IBD competition
Feb 4, 2026 2:52pm
